NASDAQ Equity Snapshot

SGMT Weekly Equity Report

Sagimet Biosciences Inc. Series A Common Stock

Interactive chart JSON snapshot
Latest Close 6.48 USD 12 Jun 2026
1W Return -4.1% latest completed week
4W Return -6.1% short-term follow-through
12W Return 34.4% quarterly tape
Trend Breadth 48.1% 25 of 52 weeks active
Volume Ratio 0.5x vs 13-week average
Company Brief

What the company does

Sagimet Biosciences Inc. (SGMT) is a forward-looking biotechnology firm dedicated to pioneering treatments for metabolic diseases, with a particular focus on non-alcoholic steatohepatitis (NASH). The company is advancing its lead therapeutic candidate through multiple clinical trial stages, leveraging innovative mechanisms aimed at improving patient outcomes significantly. Supported by a seasoned management team and a strong intellectual property portfolio, Sagimet is well-positioned to meet the rising demand for effective therapies in the metabolic disease market, presenting a compelling investment opportunity for institutional investors in the evolving biotech landscape.

Snapshot

What the weekly tape is saying

SGMT closed the latest completed week at 6.48 USD. The 4-week return is -6.1% and the 12-week return is 34.4%. Trend Signal is active, Market Dynamics is 0.78. Setup signature: Risk-first tape with a 30/100 composite read.

Trend Signal Active
Market Dynamics No fresh buy
Price vs Trend 5.8%
Volume 0.5x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 33 Persistence of active Trend Signal over the last year and current streak.
Momentum 67 Blend of 4-week and 12-week follow-through.
Dynamics 63 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 0 Relative leadership and short-term RS change.
Volume 19 Participation compared with the 13-week volume baseline.
Risk Control 0 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 2 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
6.12 USD
Vs Trend Line
5.8%
Fair Value
5.98 USD
Vs Fair Value
8.4%
52W High
11.41 USD
52W Low
4.50 USD
Drawdown
-43.2%
Range Position
28.7%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -4.1%
4W -6.1%
12W 34.4%
26W 4.0%
52W -21.6%

Trend read

Active Streak
2 weeks
52W Active Weeks
25
52W Active Breadth
48.1%
Sector Scope
US Healthcare
Sector Rank
801 of 1038
Sector Percentile
22.9%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
0.78
4W MD Change
-16.8%
Relative Strength
-21.42
4W RS Change
-41.8%
Expectation
Undecided
Probability
51.07%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
3.3M
13W Average
7.2M
52W Average
4.2M
Vs 13W
0.5x
Vs 52W
0.8x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
11.5%
52W Volatility
9.4%
Upside Weeks
23
Downside Weeks
28
Downside Breadth
53.8%
Avg Gain / Loss
8.1% / -6.7%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
NASDAQ
Country
US
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Market Cap
450.2M

Opportunity signals

  • Trend Signal is active with a 2-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Market Dynamics is positive on the latest completed week.

Risk signals

  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 6.48 USD -4.1% 6.12 USD 5.98 USD 0.78 -21.42 3.3M On
5 Jun 2026 6.76 USD -7.3% 6.16 USD 5.97 USD 0.90 -17.08 3.3M On
29 May 2026 7.29 USD 2.8% 6.19 USD 5.97 USD 1.03 -14.74 3.0M Off
22 May 2026 7.09 USD 2.8% 6.23 USD 5.96 USD 1.09 -14.26 4.5M Off
15 May 2026 6.90 USD -10.5% 6.30 USD 5.95 USD 0.94 -15.10 3.9M Off
8 May 2026 7.71 USD 1.3% 6.31 USD 5.95 USD 0.91 -4.88 5.8M Off
1 May 2026 7.61 USD 29.9% 6.31 USD 5.93 USD 0.53 -0.26 58.8M Off
24 Apr 2026 5.86 USD -9.4% 6.30 USD 5.92 USD 0.11 -21.55 1.6M Off
17 Apr 2026 6.47 USD 22.1% 6.35 USD 5.92 USD -0.26 -11.05 2.2M Off
10 Apr 2026 5.30 USD -0.4% 6.35 USD 5.92 USD -0.80 -21.97 1.7M Off
2 Apr 2026 5.32 USD 8.8% 6.40 USD 5.92 USD -1.08 -17.67 1.5M Off
27 Mar 2026 4.89 USD 1.5% 6.46 USD 5.93 USD -1.37 -20.74 2.5M Off
20 Mar 2026 4.82 USD -7.5% 6.55 USD 5.94 USD -1.38 -24.30 1.6M Off
13 Mar 2026 5.21 USD -3.7% 6.63 USD 5.94 USD -1.44 -19.79 1.6M Off